Abstract
Background
The effects of surgical site infections (SSI) after glioblastoma surgery on patient outcomes are understudied. The aim of this retrospective multicenter study was to evaluate the impact of SSI on the survival of glioblastoma patients.
Methods
Data from SSI cases after glioblastoma surgeries between 2009 and 2016 were collected from 14 French neurosurgical centers. Collected data included patient demographics, previous medical history, risk factors, details of the surgical procedure, radiotherapy/chemotherapy, infection characteristics, and infection management. Similar data were collected from gender- and age-paired control individuals.
Results
We used the medical records of 77 SSI patients and 58 control individuals. 13 were excluded. Our analyses included data from 64 SSI cases and 58 non-infected glioblastoma patients. Infections occurred after surgery for primary tumors in 38 cases (group I) and after surgery for a recurrent tumor in 26 cases (group II). Median survival was 381, 633, and 547 days in patients of group I, group II, and the control group, respectively. Patients in group I had significantly shorter survival compared to the other two groups (p < 0.05). The one-year survival rate of patients who developed infections after surgery for primary tumors was 50%. Additionally, we found that SSIs led to postoperative treatment discontinuation in 30% of the patients.
Discussion
Our findings highlighted the severity of SSIs after glioblastoma surgery, as they significantly affect patient survival. The establishment of preventive measures, as well as guidelines for the management of SSIs, is of high clinical importance.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- SSI:
-
Surgical site infection
References
Marenco-Hillembrand L, Wijesekera O, Suarez-Meade P, et al. Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis. J Neurooncol. 2020;147:297–307. https://doi.org/10.1007/s11060-020-03451-6.
Ening G, Osterheld F, Capper D, et al. Risk factors for glioblastoma therapy associated complications. Clin Neurol Neurosurg. 2015;134:55–9. https://doi.org/10.1016/j.clineuro.2015.01.006.
Gulati S, Jakola AS, Nerland US, et al. The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma. World Neurosurg. 2011;76:572–9. https://doi.org/10.1016/j.wneu.2011.06.014.
Karsy M, Yoon N, Boettcher L, et al. Surgical treatment of glioblastoma in the elderly: the impact of complications. J Neurooncol. 2018;138:123–32. https://doi.org/10.1007/s11060-018-2777-9.
Abode-Iyamah KO, Chiang H-Y, Winslow N, et al. Risk factors for surgical site infections and assessment of vancomycin powder as a preventive measure in patients undergoing first-time cranioplasty. J Neurosurg. 2018;128:1241–9. https://doi.org/10.3171/2016.12.JNS161967.
Abu Hamdeh S, Lytsy B, Ronne-Engström E. Surgical site infections in standard neurosurgery procedures- a study of incidence, impact and potential risk factors. Br J Neurosurg. 2014;28:270–5. https://doi.org/10.3109/02688697.2013.835376.
Chiang H-Y, Kamath AS, Pottinger JM, et al. Risk factors and outcomes associated with surgical site infections after craniotomy or craniectomy. J Neurosurg. 2014;120:509–21. https://doi.org/10.3171/2013.9.JNS13843.
Davies BM, Jones A, Patel HC. Implementation of a care bundle and evaluation of risk factors for surgical site infection in cranial neurosurgery. Clin Neurol Neurosurg. 2016;144:121–5. https://doi.org/10.1016/j.clineuro.2016.03.025.
Fang C, Zhu T, Zhang P, et al. Risk factors of neurosurgical site infection after craniotomy: a systematic review and meta-analysis. Am J Infect Control. 2017;45:e123–e134134. https://doi.org/10.1016/j.ajic.2017.06.009.
Jiménez-Martínez E, Cuervo G, Hornero A, et al. Risk factors for surgical site infection after craniotomy: a prospective cohort study. Antimicrob Resist Infect Control. 2019;8:69. https://doi.org/10.1186/s13756-019-0525-3.
Nathoo N, Nadvi SS, van Dellen JR, Gouws E. Intracranial subdural empyemas in the era of computed tomography: a review of 699 cases. Neurosurgery. 1999;44:529–35. https://doi.org/10.1097/00006123-199903000-00055.
Tenney JH, Vlahov D, Salcman M, Ducker TB. Wide variation in risk of wound infection following clean neurosurgery. Implications for perioperative antibiotic prophylaxis. J Neurosurg. 1985;62:243–7. https://doi.org/10.3171/jns.1985.62.2.0243.
Barnes S, Spencer M, Graham D, Johnson HB. Surgical wound irrigation: a call for evidence-based standardization of practice. Am J Infect Control. 2014;42:525–9. https://doi.org/10.1016/j.ajic.2014.01.012.
Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) hospital infection control practices advisory committee. Am J Infect Control. 1999;27:97–132.
McClelland S, Hall WA. Postoperative central nervous system infection: incidence and associated factors in 2111 neurosurgical procedures. Clin Infect Dis. 2007;45:55–9.
Shi Z-H, Xu M, Wang Y-Z, et al. Post-craniotomy intracranial infection in patients with brain tumors: a retrospective analysis of 5723 consecutive patients. Br J Neurosurg. 2017;31:5–9. https://doi.org/10.1080/02688697.2016.1253827.
Chaichana KL, Kone L, Bettegowda C, et al. Risk of surgical site infection in 401 consecutive patients with glioblastoma with and without carmustine wafer implantation. Neurol Res. 2015;37:717–26. https://doi.org/10.1179/1743132815Y.0000000042.
Dickinson H, Carico C, Nuño M, et al. Unplanned readmissions and survival following brain tumor surgery. J Neurosurg. 2015;122:61–8. https://doi.org/10.3171/2014.8.JNS1498.
Alexiou G, Kallinteri A, Levidiotou S, et al. The influence of postoperative infection in survival of patients with high-grade gliomas. Neuroimmunol Neuroinflammation. 2015;2:18. https://doi.org/10.4103/2347-8659.149418.
Bowles AP, Perkins E. Long-term remission of malignant brain tumors after intracranial infection: a report of four cases. Neurosurgery. 1999;44:636–42. https://doi.org/10.1097/00006123-199903000-00110.
Naganuma H, Sasaki A, Satoh E, et al. Long-term survival in a young patient with anaplastic glioma. Brain Tumor Pathol. 1997;14:71–4. https://doi.org/10.1007/bf02478872.
De Bonis P, Albanese A, Lofrese G, et al. Postoperative infection may influence survival in patients with glioblastoma: simply a myth? Neurosurgery. 2011;69:864–8. https://doi.org/10.1227/NEU.0b013e318222adfa.
CDC. 2020 NHSN Surgical Site Infection (SSI) checklist. https://www.cdc.gov/nhsn/pdfs/checklists/ssi-checklist-508.pdf
Bruce J, Russell EM, Mollison J, Krukowski ZH. The measurement and monitoring of surgical adverse events. Health Technol Assess. 2001;5:1–194. https://doi.org/10.3310/hta5220.
Cruse PJ, Foord R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am. 1980;60:27–40. https://doi.org/10.1016/s0039-6109(16)42031-1.
Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13:606–8.
Nota SPFT, Braun Y, Ring D, Schwab JH. Incidence of surgical site infection after spine surgery: what is the impact of the definition of infection? Clin Orthop Relat Res. 2015;473:1612–9. https://doi.org/10.1007/s11999-014-3933-y.
Apisarnthanarak A, Jones M, Waterman BM, et al. Risk factors for spinal surgical-site infections in a community hospital: a case-control study. Infect Control Hosp Epidemiol. 2003;24:31–6. https://doi.org/10.1086/502112.
Erman T, Demirhindi H, Göçer AI, et al. Risk factors for surgical site infections in neurosurgery patients with antibiotic prophylaxis. Surg Neurol. 2005;63:107–12. https://doi.org/10.1016/j.surneu.2004.04.024.
Korinek AM. Risk factors for neurosurgical site infections after craniotomy: a prospective multicenter study of 2944 patients. The French Study Group of Neurosurgical Infections, the SEHP, and the C-CLIN Paris-Nord Service. Epidémiologie Hygiène et Prévention. Neurosurgery. 1997;41:1073–9. https://doi.org/10.1097/00006123-199711000-00010.
Korinek A-M, Baugnon T, Golmard J-L, et al. Risk Factors for Adult Nosocomial Meningitis after Craniotomy Role of Antibiotic Prophylaxis. Neurosurgery. 2006;59:126–33. https://doi.org/10.1227/01.neu.0000243291.61566.21.
L Adelaide for Lyon Bone and Joint Infection Study Group. Autologous bone flap infection following craniectomy : clinical experience in a referral center. San Diego: L Adelaide for Lyon Bone and Joint Infection Study Group; 2015.
Haruki Y, Hagiya H, Takahashi Y, et al. Risk factors for Propionibacterium acnes infection after neurosurgery: a case-control study. Journal of Infection and Chemotherapy. 2017;23:256–8. https://doi.org/10.1016/j.jiac.2016.10.003.
Kelly ME, Fourney DR, Guzman R, et al. Propionibacterium acnes infections after cranial neurosurgery. Can j neurol sci. 2006;33:292–5. https://doi.org/10.1017/S0317167100005151.
Nisbet M, Briggs S, Ellis-Pegler R, et al. Propionibacterium acnes: an under-appreciated cause of post-neurosurgical infection. J Antimicrob Chemother. 2007;60:1097–103. https://doi.org/10.1093/jac/dkm351.
Blomstedt GC. Infections in neurosurgery: A retrospective study of 1143 patients and 1517 operations. Acta neurochir. 1985;78:81–90. https://doi.org/10.1007/BF01808684.
Gaillard T, Gilsbach JM. Intra-operative antibiotic prophylaxis in neurosurgery. A prospective, randomized, controlled study on cefotiam. Acta neurochir. 1991;113:103–9. https://doi.org/10.1007/BF01403193.
Chowdhary SA, Ryken T, Newton HB. Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis. J Neurooncol. 2015;122:367–82. https://doi.org/10.1007/s11060-015-1724-2.
Auguste KI, McDermott MW. Salvage of infected craniotomy bone flaps with the wash-in, wash-out indwelling antibiotic irrigation system. Technical note and case series of 12 patients. J Neurosurg. 2006;105:640–4. https://doi.org/10.3171/jns.2006.105.4.640.
Bruce JN, Bruce SS. Preservation of bone flaps in patients with postcraniotomy infections. J Neurosurg. 2003;98:1203–7. https://doi.org/10.3171/jns.2003.98.6.1203.
Delgado-López PD, Martín-Velasco V, Castilla-Díez JM, et al. Preservation of bone flap after craniotomy infection. Neurocirugia (Astur). 2009;20:124–31. https://doi.org/10.1016/s1130-1473(09)70179-4.
Erickson DL, Seljeskog EL, Chou SN. Suction-irrigation treatment of craniotomy infections. Technical note J Neurosurg. 1974;41:265–7. https://doi.org/10.3171/jns.1974.41.2.0265.
Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96. https://doi.org/10.1056/NEJMoa043330.
Braxton EE, Ehrlich GD, Hall-Stoodley L, et al. Role of biofilms in neurosurgical device-related infections. Neurosurg Rev. 2005;28:249–55. https://doi.org/10.1007/s10143-005-0403-8.
Gristina AG, Oga M, Webb LX, Hobgood CD. Adherent bacterial colonization in the pathogenesis of osteomyelitis. Science. 1985;228:990–3. https://doi.org/10.1126/science.4001933.
Ravikumar V, Ho AL, Pendhakar AV, et al. The Use of Vancomycin Powder for Surgical Prophylaxis Following Craniotomy. Neurosurgery. 2017;80:754–8. https://doi.org/10.1093/neuros/nyw127.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Salle, H., Deluche, E., Couvé-Deacon, E. et al. Surgical Site Infections after glioblastoma surgery: results of a multicentric retrospective study. Infection 49, 267–275 (2021). https://doi.org/10.1007/s15010-020-01534-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-020-01534-0